Konruns Pharma seeks 2015 listing in Hong Kong
Beijing Konruns Pharmaceuticals Co, a maker of cancer drugs, is planning an IPO in Hong Kong, with the company filing an A-1 on Tuesday. Credit Suisse and Goldman Sachs will jointly sponsor the trade.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts